News & Updates

Show Multimedia Only
KEYNOTE-585 final analysis support perioperative pembrolizumab-chemo for G/GEJ cancer

KEYNOTE-585 final analysis support perioperative pembrolizumab-chemo for G/GEJ cancer

05 Aug 2024
1-year mortality elevated after procedural/spontaneous myocardial infarction

1-year mortality elevated after procedural/spontaneous myocardial infarction

04 Aug 2024

A significantly higher 1-year mortality is seen following procedural myocardial infarction (pMI) and spontaneous MI (spMI) with troponin peak >35x the upper reference level (URL), reports a study. On the other hand, only spMI demonstrates a significant influence on mortality for troponin levels ≤35x.

1-year mortality elevated after procedural/spontaneous myocardial infarction

04 Aug 2024
Asian patients with HFmrEF at high risk of atherosclerotic burden

Asian patients with HFmrEF at high risk of atherosclerotic burden

03 Aug 2024 byStephen Padilla

Among Asian patients with heart failure (HF), those experiencing HF with mildly reduced ejection fraction (HFmrEF) constitute a substantial burden, according to a Singapore study.

Asian patients with HFmrEF at high risk of atherosclerotic burden

03 Aug 2024